Introduction
============

The expression of emotions by writing about one\'s deepest thoughts and feelings, especially regarding stressful or traumatic experiences, has long been a means of coping with emotional strain. Anne Frank, a German Jewish girl, persecuted by the Nazi regime and hiding for a long time from its prosecutors in a small room in the Netherlands, wrote into her diary:

\"*I hope, I can confide things to you which I never could do to another person and I hope you will be a great support to me*.\" (Tagebuch der Anne Frank, 1993, S. 10, Fischer Verlag, translation by the authors.)

The common assumption that expressive writing about adverse experiences is salutary to \" body and soul \", was transformed into a subject of systematic scientific research by Pennebaker et al. \[[@R44]\], \[[@R41]\].

In his theory of emotional inhibition \[[@R44]\], Pennebaker suggests that a person, when confronted with a negative, or even traumatic event, feels the need to share his/her experience with others, expecting social support. The consequence of confiding one\'s deepest thoughts and feelings to others, however, can - depending on the response of the counterpart - also be detrimental to one\'s self-esteem, making the person feel ashamed, ridiculed or rejected. Individuals thus often inhibit the expression of negative emotions, which leads to continuously heightened autonomic arousal. In the long run, sustained inhibition has a detrimental impact on well-being by increasing the probability of all kinds of health hazards \[[@R5]\], \[[@R40]\], \[[@R61]\], \[[@R1]\].

Disclosure by expressive writing does not imply the social risk of rejection or disapproval, but should help to alleviate the emotional burden and reduce the risk of developing psychosomatic problems \[[@R43]\].

In their cognitive theory of trauma processing, Ehlers et al. \[[@R8]\] describe, besides other mechanisms, the process of re-experiencing and verbalising the trauma as a path to elaboration and integration of the experience into one\'s conscious autobiographical memory. If inhibition is no longer maintained, unpleasant and upsetting intrusions cease. Thus writing about one\'s deepest feelings and thoughts regarding a negative event should improve health by abolishing inhibition.

In a paradigmatic experimental design Pennebaker et al. began to systematically examine the effects of expressive writing on the participants\' psychological and physical health. In a series of experiments (e.g. \[[@R36]\], \[[@R37]\], \[[@R38]\], \[[@R11]\]) the research group was able to show that in order to obtain positive effects on the subjects\' health, the writing instructions had to focus the subject on the emotional evaluation of his or her experience beyond the factual description of events. The typical experimental setup consisted of 3 to 4 short sessions of writing (15 to 20 minutes each) on an individually selected upsetting experience or a predetermined stressful situation (e.g. entry into college).

The effects of this brief and rather simple intervention puzzled the research community. The results showed long-term positive effects on health (e.g. documented in a lower number of health care visits, physical symptoms or even an improvement of immunological functioning or psychological well-being). Pennebaker\'s research inspired a number of subsequent studies by different authors using his paradigm of expressive writing. In 1998 Smyth \[[@R58]\] presented a meta-analysis of 13 studies, including 8 of the Pennebaker group, examining the long-term health effects of disclosure in healthy populations. He reported an overall effect size of d=0.47, indicating a significant, yet medium sized, effect of this brief and economic intervention, which suggested its usefulness as a tool for health promotion.

A large number of studies have been conducted since, expanding the application of the intervention from normal healthy subjects to individuals with specific health risks and clinical samples \[[@R12]\], as well as varying experimental parameters of the original design (number and duration of sessions, type of outcome data, instructions, time of follow-up assessment etc.) The large number of currently published studies makes it difficult to evaluate the state of evidence regarding the physical and psychological consequences of the expressive writing intervention.

The objective of our study was to determine the long-term effects of expressive writing particularly on physical and psychological health as studied in methodologically adequate studies (randomized controlled trials; RCTs). A meta-analysis was conducted to answer the following research questions:

Is expressive writing efficacious in improving health and what is the size of the effects?Does efficacy differ regarding physical and psychological health parameters as outcome variables?

Methods
=======

Literature search
-----------------

Relevant studies were located by searching the following data bases: PsychInfo, Psyndex, PubMed, Medline and the Cochrane Library. The keywords used for the search were selected on the basis of the previous meta-analyses by Smyth \[[@R58]\] and Frisina et al. \[[@R12]\] using the following terms: Pennebaker, self-disclosure, disclosure and writing, self-disclosure and health, writing and stressful life events, critical life events and writing, written emotional expression, emotive writing, emotional expression and writing, and the German keywords \"Selbstöffnung" and "Trauma and Schreiben\". The computer search was supplemented by a manual search in relevant journals, having frequently published papers on disclosure, and by examining various reviews \[[@R22]\], \[[@R55]\], \[[@R12]\], \[[@R58]\].

Furthermore e-mail contact was established with different authors in the field in order to identify undiscovered or non-published studies (e.g. J.W. Pennebaker, J.M. Smyth, R. Rosenthal, D.M. Sloan, B.P. Marks). This strategy resulted in 10 more papers. In total, the search resulted in 216 identified studies, which were then examined for relevance.

Inclusion criteria
------------------

Only randomized controlled trials were included in meta-analysis, which ensures a high degree of internal validity of the results. The conceptual and interventional similarity to the disclosure paradigm, developed by Pennebaker et al., was ensured by the following criteria:

The experimental group is instructed to write on an experienced stressful or traumatic life event.The control group is instructed to write on a neutral factual event/topic. No instructions or interventions which foster verbal or motor expression of emotions or emotional thoughts in the control group were performed.If the experimental group received some further intervention in addition to expressive writing (e.g. psychotherapy), this also had to be carried out in the control group.Only long-term effects of disclosure were analyzed, defined by an interval of at least 4 weeks between the last writing session and the follow-up assessment.In the post-follow-up period, no contacts with the experimenter were allowed.Each specific data set was considered only once (in spite of multiple publications).The study had to comprise at least 10 subjects per group.The study had to be reported in English or German language.

The application of these criteria reduced the number of studies to be included in the meta-analysis to 42. In order to be able to calculate effect sizes, studies had to report means and standard deviations, F-Scores, t-scores or significance levels including the number of subjects.

Coding of variables
-------------------

A coding manual (i=53) was compiled according to Lipsey\`s \[[@R29]\] suggestions including variables related to external characteristics of the study (e.g. year of publication), so called substantial characteristics (like data relevant to the topic of research) and biasing characteristics (e.g. randomization). To ensure interrater reliability two authors (1 and 2) independently coded 4 randomly selected studies for training purposes and then discussed the cases of non-correspondence. After that, 8 studies were randomly selected to determine interrater reliability, Cohen\'s Kappa for multinomial data and intraclass coefficients for rank and interval data \[[@R51]\]. The mean inter-rater reliability was \"excellent\" (Kappa=0.85, see \[[@R34]\]). Very few items had a Kappa lower than 0.40 (i=4). All items with low inter-rater reliability were not substantial to the conduction of the meta-analysis and interpretation of the results.

Effect size calculation
-----------------------

All outcome variables related to health were categorized into 3 classes:

Somatic health including physiological parameters (e.g. killer cell count) and somatic symptoms (e.g. headache, dizziness).Psychological health (e.g. depressiveness, anxiety, PTSD symptoms, negative affect and mood).Miscellaneous (e.g. grades, self efficacy).

The 3^rd^ category was analysed for comparative reasons in a separate analysis and is not included in the test of general health effects.

Hedges\' \<g\> was used as measure of effect size \[[@R19]\], which differs from the conventional \<d\> by dividing the difference of means, by the pooled standard deviation. To offset bias produced by small sample sizes, a correction formula was applied as suggested by Hedges & Olkin \[[@R19]\]. Data used for effect size calculation was entered into the computer program \"Study Input\" \[[@R52]\].

If categorical data was presented, odds ratios were calculated, which were then transformed into g by a strategy suggested by Fleiss \[[@R10]\]. If only probability levels were reported, effect size was set to zero in case of non-significance. Only one effect size for each category of variables per study (mean) was entered into the meta-analysis. If a study contained more than one disclosure group or more than one control group, effect sizes were averaged. All measures were scored in such a way that if the experimental group was superior to the control group, a positive effect size resulted.

Model of analysis
-----------------

Effect sizes of single studies are commonly integrated into one score, which represents an estimate of the \"true\" effect. In the fixed effects model (FEM) it is assumed that all original study effect sizes estimate a common population effect, best defined by the mean effect size of all studies. Deviations in single studies are attributed to a sampling error. To examine this assumption a test on homogeneity has to be performed \[[@R54]\]. The implication of this model is a limited generalization of the results to other studies. Therefore the random effects model (REM \[[@R6]\]) was used in the main analyses.

The REM accounts for a certain component of variance (random effects variance), which is not part of the sampling error, but is created by systematic factors of the study design (e.g. different assessment procedures, different intervention formats), and is tested regarding its significance \[[@R51]\]. If the variance deviates significantly from zero (≥0.05), a test for moderators of effect size is suggested \[[@R48]\]. The desirable implication of REM is that the results of meta-analysis can be generalized to the universe of studies on the topic (with some limitations: e.g. only RCT studies). To ensure this generalisability of results it is suggested to include at least 15 studies into meta-analysis \[[@R9]\]. If markedly fewer studies are included, random effect tests should be regarded as only approximate \[[@R20]\].

Sensitivity analyses \[[@R16]\] are carried out to test whether different decisions regarding the procedure of meta-analysis (integration of effects) lead to different results.

Furthermore, results of a meta-analysis can be distorted by a publication bias, assuming that the under-representation of non-published studies leads to an overestimation of effect size. Orwin\'s \"fail safe n\" statistic \[[@R33]\] assesses the stability of meta-analytic results by estimating the number of null results necessary to lower an effect size to a specific level of significance.

Results
=======

Of the 42 relevant studies 30 presented data which could be used for the meta-analysis (Table 1 [(Tab. 1)](#T1){ref-type="fig"}). Seven of the 42 studies had to be excluded because they did not report adequate information for effect size calculation and the respective authors did not react to our contact efforts. Another 5 studies had to be excluded because they failed to meet the inclusion criteria, which became apparent only after closer inspection of the published papers.

Of all 30 studies 27 used pure randomization for the allocation of Ss to conditions and 3 used a matching procedure prior to randomization. 20 studies were published after 2000, only 3 before 1990. The mean age of Ss was 27 years, most of them were female (64.7%). In 17 studies students were involved, 8 studies included \"high risk\" samples (Ss who had experienced an adverse event that made them vulnerable, e.g. victims of a hurricane, early sexual abuse). Four studies included clinical samples (e.g. Ss with asthma, PTSD) (Table 1 [(Tab. 1)](#T1){ref-type="fig"}). The number of sessions for expressive writing varied between 1 and 5 (mean 3.2 with a duration between 15 and 20 minutes). The follow-up period for the assessment of long-term health effects varied between 4 weeks and 8 months. The average number of Ss was 64 and the mean drop-out rate 12.1%.

For the examination of *baseline differences* between experimental and control groups effect sizes were computed and integrated for each study. The FE model was used in this case because of a smaller confidence interval. Two studies had to be excluded from this analysis, since they did not present adequate data on baseline variables.

None of the studies had a positive/negative effect size with a confidence interval of 95% not comprising zero. Thus a non-significant effect of g=-0.07 (*σ*^2^=0.00), CI~95~=-0.16-0.03) results. A test on the subset of psychological health variables from 14 studies leads to a similar result (g=-0.12, *σ*^2^=0.00, CI~95~=-0.25-0.00). The analysis of somatic health variables also renders non-significant results regarding baseline differences (K=20; g=0.05, *σ*^2^=0.0, CI~95~=-0.16-0.06).

Before meta-analyses regarding efficacy of the expressive writing interventions (difference between experimental and control group) were conducted, an outlier analysis was performed. The study of Greenberg et al. \[[@R15]\] showed a large number of effect sizes that lay more than 2 standard deviations above/below the mean of all effect sizes (Figure 1 [(Fig. 1)](#F1){ref-type="fig"}) and was hence eliminated from further analysis.

We used the RE model to calculate the effect sizes for the expressive writing intervention with respect to *all* health related variables. This yielded a non-significant effect size (K=27, g=0.04, *σ*^2^=0.003, *σ~θ~*^2^=0.01, CI~95~= -0.08-0.15). The RE variance did not reach significance.

The subset of psychological variables (K=19) was analysed separately, resulting in an effect size of g=0.01 (*σ*^2^=0.01, *σ~θ~*^2^=0.01, CI~95~=-0.17-0.19), which did not reach significance.

The analysis of somatic health variables (K=24) rendered an effect size of g=0.07 (*σ*^2^=0.00, *σ~θ~*^2^=0.01, CI~95~=-0.06-0.19), which is not significant. The critical difference of chi^2^ 3.84 at a≤0.05 between the categories of health related variables was not reached. Thus, no significant differences between outcome categories regarding efficacy can be detected.

Furthermore a series of exploratory analyses were performed. The analysis of effects of health behaviour variables (K=16, e.g. visits to physicians or health care centres, sick days, drug use, smoking, alcohol consumption, sleeping and eating habits, sports) yielded a significant effect size of g=0.2 (*σ*^2^=0.02, *σ~θ~*^2^=0.1, CI~95~=0.04-0.36).

Also all self-reported somatic health symptoms and all objective physical variables (e.g. immune parameters, breathing parameters) were analysed separately. Both analyses rendered non-significant results (K=14, g=-0.05, *σ*^2^=0.00, CL~95~=-0.18-0.09; K=4, g=0.01, *σ*^2^= 0.02, CL~95~=-0.27-0.29)

Because of its special relevance regarding the concept of expressive writing, an exploratory analysis (K=6) with respect to posttraumatic symptoms was conducted in order to test for a specific effect on the symptoms of arousal, intrusion and avoidance. The effect size turned out to be insignificant g=-0.10 (*σ*^2^=0.02, *σ~θ~*^2^=0.04, CI~95~=-0.25-0.46).

A last exploratory analysis was conducted separating studies with \"high risk\" and \"normal\" samples. An insignificant g analysed over all health variables was found in both analyses (students: K=16, g=0.07, *σ*^2^=0.00, CI~95~=-0.03-0.22/high risk: K=7, g=-0.03, *σ*^2^=0.01, CI~95~=-0.06-0.20). The 4 studies on clinical samples were also analysed, resulting in a g=0.08 (*σ*^2^=0.01, CI~95~=-0.15-0.31).

The group of studies presenting variables not directly related to health (see \"miscellaneous\", K=8) was also examined and revealed a g=0 (*σ*^2^=0.01, *σ~θ~*^2^=0.01, Cl~95~=-0.19-0.26).

Sensitivity analyses were carried out by separately analysing studies, where effect size computations were based on means, sd, n, or on significance reports only. No difference of any importance was found. An analysis including the study of Greenberg et al. \[[@R15]\] led to the same negative results regarding effect sizes as well. The significant g of 0.2 (health behaviour) equals the lowest relevant effect size to be tested against \[[@R33]\], thus the fail safe n statistic could not be calculated.

Discussion
==========

Our meta-analysis including 30 studies using a randomized controlled design presents effect sizes regarding the long-term efficacy of expressive writing with respect to somatic and psychological health. The long-term effects regarding the different outcome categories do not differ from one-another. When averaging over all outcome categories, again no significant effect size is found. These negative results cannot be explained by differences between experimental and control groups at baseline, since no differences could be detected. Thus, our analysis does not support the hypothesized beneficial effect of disclosure by writing about stressful or traumatic experiences as it was originally suggested by Pennebaker.

None of the additional exploratory or sensitivity analyses led to a detection of significant effects, with the exception of the category of health behaviours. The observed effect size is very small, with the confidence interval at the lower end exceeding zero just marginally. PTSD symptoms, which should be very sensitive to the impact of disclosure, were not decreased after the intervention. Furthermore, it was of no importance whether \"high risk\", clinical or normal samples were involved.

In the light of the relatively high number of original studies that were incorporated in all main analyses (\>13), these results are deemed to be very robust. As the RE model was applied in all main analyses, generalisability of results is warranted.

Thus our study leads us to a conclusion which is contrary to the one derived from the analysis performed by Smyth \[[@R58]\], who obtained an average effect size of a medium level, varying dependent on the analysed outcome category between d=0.03 (health behaviours) and d=0.66 (psychological well-being). When considering possible explanations for the differences between these analyses, it is evident that our analysis is based on markedly more original studies than the previous one (included studies 13 vs. 30), with 8 of our studies also being part of Smyth\'s analysis. In contrast to the earlier study, our analysis could fulfil, at least regarding the general health effects, the criterion of 15 analysed studies and can, therefore, claim generalisability of results. Also, our rather conservative methodology may have contributed to the different outcome (use of g, correction formula for small n).

In a recent study Frisina et al. \[[@R12]\] examined 9 studies on the health outcomes in \"clinical populations\". Similar to our study, the authors included only RCTs. The mean effect size the authors obtained was different from zero (d=0.19, p\<0.05), but markedly smaller than that found by Smyth. The results show that the disclosure intervention was significantly more effective regarding physical health than psychological health (d=0.07 vs. d=0.21), or rather that a beneficial effect of expressive writing could only be detected regarding physical health variables. However, direct comparability of Frisina\'s et al. analysis and ours is limited. Because of different selection criteria, only one of their 9 original studies was included in our analysis. Their finding of a general efficacy, however, even below the suggested standard for \"small\" efficacy (d=0.2) could not be replicated in the present meta-analysis, which included mainly non-clinical studies.

The assumption that clinical samples might profit more than non-clinical samples by emotional writing is not corroborated by our explorative analysis. However, the number of clinical trials included in our study is small.

The results of our analyses give no reason to believe that emotional writing about stressful experiences in a structured setting - as used in the disclosure paradigm - is an effective tool for the reduction of health risks supposed to be the sequelae of emotional inhibition.

However, it cannot be excluded that under particular context conditions and in particular groups of Ss positive outcome reflected in selected parameters of health may be observed (see e.g. \[[@R55]\], \[[@R13]\], \[[@R26]\]). However these conditions cannot be specified at the moment and only speculations can be offered. It has already been proposed that only individuals stressed by adverse bio-psychosocial conditions may profit from expressive writing. Additional instructions accompanying the standard emotional writing procedure could be crucial, e.g. instructions that foster self-regulatory coping, self-efficacy or helping others (see e.g. \[[@R28]\], \[[@R27]\], \[[@R4]\], \[[@R13]\], \[[@R31]\]).

Since in most studies pre-experimental extent of \"disclosure\" in the individual is not controlled, this might be a relevant condition. The type of the trauma concerned could be a relevant factor as well as the fact of whether it is still prevailing or a past experience (see \[[@R58]\]).

According to the theory of memory elaboration it should be examined whether the cognitive-emotional quality of the written essays is predictive of health improvement. There have mostly been only very basic attempts to determine the content of the essays (e.g. \[[@R38]\], \[[@R32]\]), but a more sophisticated method of determining the extent of \"self-exploration\", based on Carl Roger\'s theory did not yield any promising perspective \[[@R26]\].

In this meta-analysis a search for moderators of effect sizes was not performed since minimal or no significant effect sizes were found and the detected variance did not reach a size suggesting this procedure.

The validity of our findings is supported by a meta-analysis by Meads et al. \[[@R30]\], which came to our knowledge after our study had been planned and conducted. The authors incorporated even more original studies than the current analysis, since they did not restrict their analysis to emotional writing but also included other forms of disclosure. Similar to our study they excluded non-randomized studies, but differed regarding the definition of long-term outcome. They included follow-up data assessed at a minimum interval of one week whereas we used a one month criterion. Also, they included studies into their analysis with samples of n\<10. In spite of these differences, the authors come to the same conclusion: \"There is no clear evidence to demonstrate the efficacy of the intervention reviewed.\" (see executive summary, \[[@R30]\]).

One further meta-analysis by Harris \[[@R18]\], which has been published just recently, examined whether expressive writing affects health care utilization behaviours. Based on 13 studies Harris finds a small but significant effect only in healthy samples (g=0.16) but not in samples defined by medical diagnoses or exposure to stress or other psychological factors.

Thus all recent meta-analyses lead to the same general conclusion: Expressive Writing or other forms of disclosure do not lead to long term momentous positive health effects. The results of our review do not allow one to recommend the procedure of expressive writing to individuals having experienced stressful or traumatic experiences to avert negative consequences on their health. The findings, documented in these reviews, either call into question the intervention formats inducing disclosure used so far, or suggest a revision of the theory of emotional inhibition and disclosure. Books titled "Opening Up: The Power of Healing." \[[@R42]\] or "Writing to Heal: A Guided Journal for Recovering from Trauma and Emotional Upheaval" \[[@R45]\] are qualified to misdirect the public since they induce expectations and hopes not likely to be met.

Notes
=====
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